These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38030599)

  • 21. Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome.
    Talwalkar SS; Yin CC; Naeem RC; Hicks MJ; Strong LC; Abruzzo LV
    Arch Pathol Lab Med; 2010 Jul; 134(7):1010-5. PubMed ID: 20586629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome.
    Barlow JW; Mous M; Wiley JC; Varley JM; Lozano G; Strong LC; Malkin D
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1403-6. PubMed ID: 15298965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Super-Transactivation TP53 Variant in the Germline of a Family with Li-Fraumeni Syndrome.
    Id Said B; Kim H; Tran J; Novokmet A; Malkin D
    Hum Mutat; 2016 Sep; 37(9):889-92. PubMed ID: 27297285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site.
    Chen S; Wu JL; Liang Y; Tang YG; Song HX; Wu LL; Xing YF; Yan N; Li YT; Wang ZY; Xiao SJ; Lu X; Chen SJ; Lu M
    Cancer Cell; 2021 Feb; 39(2):225-239.e8. PubMed ID: 33357454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation.
    Yamazaki F; Shima H; Osumi T; Narumi S; Kuroda T; Shimada H
    J Pediatr Hematol Oncol; 2018 Apr; 40(3):e195-e197. PubMed ID: 28902083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
    Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y
    Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes.
    Ruijs MW; Schmidt MK; Nevanlinna H; Tommiska J; Aittomäki K; Pruntel R; Verhoef S; Van't Veer LJ
    Eur J Hum Genet; 2007 Jan; 15(1):110-4. PubMed ID: 17003841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage.
    Zerdoumi Y; Lanos R; Raad S; Flaman JM; Bougeard G; Frebourg T; Tournier I
    Hum Mol Genet; 2017 Jul; 26(14):2591-2602. PubMed ID: 28369373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
    Kamihara J; Rana HQ; Garber JE
    Hum Mutat; 2014 Jun; 35(6):654-62. PubMed ID: 24706533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
    Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
    J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
    Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V
    Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of TP53 germline variants and their correlations with Li-Fraumeni syndrome or Li-Fraumeni-like syndrome in Chinese tumor patients.
    Tian P; Zhang X; Yang S; Fang Y; Yuan H; Li W; Zhu H; Zhao F; Ding J; Zhu Y; Wang S; Sun G; Ni H; Ma T; Lei T
    J Genet Genomics; 2022 Jul; 49(7):645-653. PubMed ID: 35033608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties.
    Song H; Wu J; Tang Y; Dai Y; Xiang X; Li Y; Wu L; Wu J; Liang Y; Xing Y; Yan N; Li Y; Wang Z; Xiao S; Li J; Zheng D; Chen X; Fang H; Ye C; Ma Y; Wu Y; Wu W; Li J; Zhang S; Lu M
    Sci Transl Med; 2023 Apr; 15(690):eabn9155. PubMed ID: 37018419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
    Macedo GS; Vieira IA; Vianna FSL; Alemar B; Giacomazzi J; Brandalize APC; Caleffi M; Volc SM; de Campos Reis Galvão H; Palmero EI; Achatz MI; Ashton-Prolla P
    Fam Cancer; 2018 Apr; 17(2):269-274. PubMed ID: 28756477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis.
    Marcel V; Palmero EI; Falagan-Lotsch P; Martel-Planche G; Ashton-Prolla P; Olivier M; Brentani RR; Hainaut P; Achatz MI
    J Med Genet; 2009 Nov; 46(11):766-72. PubMed ID: 19542078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of late-onset Li-Fraumeni-like syndrome with unilateral breast cancer.
    Cho Y; Kim J; Kim Y; Jeong J; Lee KA
    Ann Lab Med; 2013 May; 33(3):212-6. PubMed ID: 23667851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition.
    Valdez JM; Nichols KE; Kesserwan C
    Br J Haematol; 2017 Feb; 176(4):539-552. PubMed ID: 27984644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Li-Fraumeni syndrome and Li-Fraumeni-like families for germline mutations in Bcl10.
    Stone JG; Eeles RA; Sodha N; Murday V; Sheriden E; Houlston RS
    Cancer Lett; 1999 Dec; 147(1-2):181-5. PubMed ID: 10660104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic modeling of Li-Fraumeni syndrome in zebrafish.
    Parant JM; George SA; Holden JA; Yost HJ
    Dis Model Mech; 2010; 3(1-2):45-56. PubMed ID: 20075382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family.
    Evans SC; Mims B; McMasters KM; Foster CJ; deAndrade M; Amos CI; Strong LC; Lozano G
    Hum Genet; 1998 Jun; 102(6):681-6. PubMed ID: 9703430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.